Healio

FDA grants premarket approval to Idylla CDx MSI test for patients with colorectal cancer

The FDA has approved the Idylla CDx MSI test — a fully automated, “sample-to-result” companion diagnostic — for patients with ...

California Resources (CRC) Engages In M&A Discussions With Berry Corporation

California Resources (CRC) recently held discussions regarding potential mergers and acquisitions with Berry Corporation, ...
Medscape

FDA OKs First Multitarget Stool RNA Test for CRC Screening

The US Food and Drug Administration (FDA) has approved ColoSense (Geneoscopy, Inc), a multitarget stool RNA (mt-sRNA) test for colorectal cancer (CRC) screening in adults aged 45 or older who are at ...
Yahoo Finance

California Resources (CRC) Concludes Merger With Aera Energy

California Resources Corporation CRC has concluded its $1.13 billion all-stock merger, announced in February 2024, with Aera Energy, LLC. The total valuation of the deal is $2.1 billion, including ...
Medscape

CRC Outcomes Better When First of Multiple Cancers

Colorectal cancer (CRC) survival is longer when it’s the first of multiple primary malignancies than when it’s the second or solo, new data suggest. The findings came from a retrospective analysis of ...